SOUTH SAN FRANCISCO, Calif., Sept. 17, 2013 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime) announced today the pricing of its initial public offering of 4,800,000 shares of its common stock at a price of $13.00 per share for an aggregate offering of $62.4 million, before underwriting discounts, commissions and expenses. All of the shares of common stock are being offered by Five Prime. In addition, Five Prime has granted the underwriters a 30-day option to purchase up to 720,000 additional shares of common stock at the initial public offering price to cover over-allotments, if any.
Five Prime Therapeutics Announces Pricing Of Initial Public Offering
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.